UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034609
Receipt number R000039456
Scientific Title Assessment of early diabetic nephropathy using Functional MR imaging
Date of disclosure of the study information 2019/01/01
Last modified on 2022/10/26 17:32:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Assessment of early diabetic nephropathy using Functional MR imaging

Acronym

Functional imaging of early diabetic nephropathy

Scientific Title

Assessment of early diabetic nephropathy using Functional MR imaging

Scientific Title:Acronym

Functional imaging of early diabetic nephropathy

Region

Japan


Condition

Condition

Diabetic nephropathy

Classification by specialty

Endocrinology and Metabolism Nephrology Radiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To assess the renal function of early stage diabetic nephropathy using functional MR imaging

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Usefulness of MR imaging to evaluate early stage diabetic nephropathy

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

diabetic nephropathy Staying still for 30 minutes to perform MR imaging

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patients of diabetic nephropathy or Healthy volunteer

Key exclusion criteria

The patients who have renal disease other than diabetic nephropathy

Target sample size

120


Research contact person

Name of lead principal investigator

1st name Akira
Middle name
Last name Yamamoto

Organization

Kawasaki Medical School

Division name

Radiology

Zip code

7010192

Address

577 Matsushima Kurashiki Okayama Japan

TEL

086-462-1111

Email

jiro@med.kawasaki-m.ac.jp


Public contact

Name of contact person

1st name Akira
Middle name
Last name Yamamoto

Organization

Kawasaki Medical School

Division name

Radiology

Zip code

7010192

Address

577 Matsushima Kurashiki Okayama Japan

TEL

086-462-1111

Homepage URL


Email

jiro@med.kawasaki-m.ac.jp


Sponsor or person

Institute

Depertment of Radiology Kawasaki Medical School

Institute

Department

Personal name



Funding Source

Organization

Kawasaki Medical School

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Kawasaki Medical School

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Research ethics committee of Kawasaki Medical School and Hospital

Address

577 Matsushima Kurashiki Okayama Japan

Tel

086-462-1111

Email

kmsrec@med.kawasaki-m.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2018 Year 09 Month 10 Day

Date of IRB

2018 Year 12 Month 05 Day

Anticipated trial start date

2019 Year 01 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

As of October 25, 2020, MRI was performed after obtaining consent from 28 patients with diabetic nephropathy.
As of October 26, 2022, MRI was performed after obtaining consent from 99 patients with diabetic nephropathy.


Management information

Registered date

2018 Year 10 Month 23 Day

Last modified on

2022 Year 10 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039456


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name